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*S Supporting Information
ABSTRACT: Cyclotriveratrylene (CTV) is a macrocyclic cyclophane presenting a bowl-
shaped conformation, used as building block to construct cryptophane and hemi-
cryptophane capsules. A method to synthesize new enantiopure CTV derivatives with an
unprecedented spatial arrangement of their substituents, exhibiting C1 symmetry, is
described. The absolute configuration was assigned by ECD spectroscopy coupled with
modeling. A statistical model has allowed for optimization of the proportion of C1 CTV,
and the modularity of this approach is also highlighted.
Cyclotriveratrylene (CTV) 1 is a macrocyclic trimer ofveratrole presenting a bowl-shaped conformation (Figure
1a).1 The first synthesis of the CTV was achieved
independently by Ewins and Robinson in 1909 and 1915,
respectively.2 In 1965, Lindsey, Erdtman, and Goldup
proposed a revised structure describing a macrocryclic trimer
of aromatic rings.3 Since then, various CTV analogues have
been obtained by changing the nature of the R1/R2
substituents at their side arms (2, Figure 1b).1 When R1
differs from R2, the CTV derivatives are chiral, and the
resulting racemic mixture can be resolved.4 Members of the
CTV family have attracted considerable attention due to their
usefulness for versatile applications ranging from separations,5
sensing,6 gels,7 and dendrimers8 to liquids crystals.9 Moreover,
they have been also used as building blocks for the
construction of supramolecular assemblies such as polymers,10
cubes,11 pseudorotaxanes,12 catenanes13 and capsules.1,14 In
particular, the combination of two CTV derivatives, linked
together, gives molecular capsules, named cryptophanes,14,15
which present remarkable recognitions properties toward small
molecules like epoxydes and methane,16,17 cations like choline
and cesium, and anions.18,19 They were also found to complex
Xe atom,20 leading to promising tools for bioimaging.21 When
the CTV moiety is connected with another C3 symmetrical
unit, it gives rise to hemicryptophanes.22 These chiral covalent
cages can act as receptors for neurotransmitters and
carbohydrates,23,24 molecular switches,25 and supramolecular
catalysts.26
While most CTV or CTV-based hosts reported so far
present a C3 symmetry, few C1-symmetrical CTVs have been
described in the literature.27 This change of the symmetry
results from the introduction of an R3 group, different from R1
and R2, on one of the aromatic rings, for instance, by
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Figure 1. (a) Structure of the cyclotriveratylene 1. (b) General
structure of chiral CTV derivatives 2 with C3 symmetry (R1 ≠ R2). (c)
Classical approach to obtain C1 CTV derivatives. (d) Strategy of
Becker et al.27d (e) Our approach.
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monodemethylation of the CTV unit (compound 3, Figure 1c)
or by monoiodation of a C3 CTV derivative.
27b,c Becker et al.
have recently reported the synthesis of the C1 CTV-lactam 4
through the original functionalization of one of the apical
position of the CTV moiety (Figure 1d).27d However,
compound 4 turns out to be more flexible than the “classical”
CTV moiety, leading to a lower energy barrier of racemization
and avoiding their resolution by chiral HPLC. To the best of
our knowledge, the straightforward synthesis of C1-symmetrical
CTV derivatives, where the loss of symmetry arises from the
permutation of the substituents R1 and R2 (Figure 1e) on one
of the aromatic ring is currently rather uncommon.27e
Importantly, such an approach will lead to C1-derivatives
with an original spatial arrangement of their substituents,
which will be highly valuable in order to access to
cryptophanes and hemicryptophanes with shapes and sizes of
their cavity that cannot be achieved by the existing methods.
Herein, we propose a new C1 CTV structure where the loss
of symmetry is due to an inverted arrangement of one aromatic
ring. The unmodified CH2 bridges, found in this structure, aim
at maintaining its conformational rigidity, allowing for its
resolution; meanwhile the specific arrangement of the
substituents could afford a new chiral cyclophane building
block, with a bowl-shaped conformation. We therefore report
the synthesis of a CTV derivative, where the sequential
distribution of the R1/R2 substituents is reversed on one of the
aromatic ring (Figure 1e). To favor the formation of the C1
over the C3 CTV, we optimized the reaction conditions by
mean of a statistical model. The racemic mixture was resolved
by chiral HPLC and the assignment of the absolute
configuration was achieved by ECD spectroscopy. Other
related C1 CTVs were prepared to highlight the modularity of
our approach and X-ray diffraction analyses confirm the
proposed structures.
C1 CTV 5 bearing allyl and bromoethyl substituents was
synthesized by mixing the two regio-isomers 6 and 7 in a 4:1
ratio in acetonitrile using scandium triflate as Lewis acid
catalyst (Scheme 1). A mixture of C3- and C1-symmetric CTVs
8 and 5, respectively, was obtained in 52% yield after removal
of the byproducts of the reaction (oligomers and polymers) by
column chromatography. The four isomers (+)-8, (−)-8,
(+)-5, and (−)-5 were separated on chiral HPLC (see Figures
S76 and 77), allowing isolation of each enantiomer of the CTV
5 on a gram scale. Both compounds 8 and 5 display identical
mass spectra (Figures S56−S57); however the 1H NMR
spectrum of enantiopure CTV 8 confirms the C3 symmetry,
whereas that of enantiopure 5 exhibits a more complex pattern
(Figures S26 and S28). For instance, the characteristic signals
corresponding to the Ha protons of the AB systems of the CH2
bridges in 5 appear as the superposition of three doublets at
4.71 ppm, with an expected coupling constant around 13.6 Hz,
and the aromatic protons of the three CTV units give six
singlets between 6.85 and 6.95 ppm.
The chiroptical properties of the two enantiomers of 5 were
then studied. Their optical rotations, measured in CH2Cl2 at
589 nm, correspond to a third of that of their C3 parents (±5
and ±15 deg cm2 g−1, respectively (see the Supporting
Information)). Similarly, their electronic circular dichroism
(ECD) spectra, recorded in MeCN at 25 °C (Figures 2 and
Figures S94 and S95), also exhibit a decrease of the intensities
for the observed transitions by two-thirds compared to their C3
counterparts. The inverted position of one of the aromatic
rings probably induces two excitons coupling of the same sign
and one of the opposite and could account for this
experimental result. The assignment of the absolute config-
uration of the C1 CTV was then achieved. First, the
stereodescriptor was chosen according to the method
described by Prelog.28 However, because of the lack of the
C3 axis, the conformations around the six CH2−Ar single
bonds are no more equivalent. The priority of one pair can be
determined according to CIP rules, and the procedure of
Prelog can be applied, giving a M descriptor, if R1 > R2, for the
enantiomer drawn in Figure 1e (see the Supporting
Information for more details).28 Second, this stereodescriptor
was linked with a chiroptical property so that their electronic
circular dichroism (ECD) spectra were thus used to achieve
this goal. Indeed, the spectra exhibit two exciton patterns
centered on the isotropic absorption of the 1La (∼240 nm) and
1Lb (∼290 nm) transitions, as usually observed for CTV
analogues. Collet et al. have demonstrated that the sign of the
bands of the experimental ECD spectrum around the 1La ∼
240 nm is poorly sensitive to the nature of CTV derivatives
substituents. Therefore, the determination of their absolute
configuration was achieved by means of comparison to the
calculated ECD spectra of a reference CTV.29 On the basis of
these previous works, the second and third eluted compounds
Scheme 1. Synthesis of C1 CTV 5
a
aA mixture of four stereoisomers is obtained: (+)-8, (−)-8, (+)-5, and
(−)-5.
Figure 2. Experimental ECD spectra of the enantiomers of 5: the first
eluted enantiomer is represented with a green solid line (0.404 mmol
L−1 in CH2Cl2) and the second one by a red dotted line (0.442 mmol
L−1 in CH2Cl2) together with TDDFT calculations performed for M-
5. Calculations were carried out at the CAM-B3LYP/SVP/PCM-
(MeCN) level of theory; spectrum red-shifted by 33 nm, Gaussian
bandwidth 0.23 eV, similarity factor assigned by means of SpecDis
ver. 1.70 for the second peak = 0.833, while for the first one = 0.008.30
((+)-5 and (−)-5, respectively) correspond to the P and M
configurations, whereas the first and fourth eluted compounds
((+)-8 and (−)-8, respectively) correspond to the P and M
configurations of the C3 CTV. To confirm this stereochemical
assignment, ECD spectra were calculated for an arbitrary
chosen M-5 by using the TDDFT method. In order to
guarantee the quality of the obtained data, two hybrid
functionals (CAM-B3LYP, ωB97X-D) with the SVP basis set
and PCM model for MeCN were tested. The results are
completely in agreement. This confirms the aforementioned
assignment; i.e., the second eluted peak is M-5, while the first
one is P-5 (Figure 2).
We then focused our attention on the improvement of the
C1/C3 ratio (5/8 ratio) by varying the initial proportions of the
starting regioisomers 6 and 7. The proportions of C3 and C1
CTV derivatives can be explained by a simple statistical model,
assuming (i) a kinetic model for the reaction, (ii) that both
isomers 6 and 7 have the same reactivity, and (iii) that the
racemization of the CTVs C1 and C3 occurs frequently during
the reaction time (see the Supporting Information). This latter
hypothesis was assessed by measuring the energy barrier of the
C1 enantiomer. A value of 112.1 kJ mol
−1 was found, similar to
that of its C3 parent, which corresponds to a half-life time of 24
min at 82 °C (Figures S100 and S101). With this model for the
cyclization, the probabilities are given by the polynomial law
with Newton’s binomial coefficients
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where x is the proportion of regioisomer and PC1(x) and PC3(x)
the probabilities to obtain the C1 and C3 CTV, respectively.
Thus, from these equations we find that the maximum of the
function PC1 is reached for an equimolar mixture of each
regioisomer (x = 0.5) and yields a maximum of 75% of C1
derivative and 25% of C3 derivative. To confirm this model,
several cyclizations were performed under the same conditions
with different proportions x of the starting regioisomer 7. The
proportions PC1 and PC3 were both determined by
1H NMR
and HPLC (Figures S65−S74). The statistical model was
found to be in excellent agreement with the experiments,
confirming our hypothesis (Figure 3). Moreover, it supports
that the optimal conditions for the synthesis of C1 derivative
are reached when an equimolar mixture of both isomers is
used, leading to a maximum yield of 75% of C1 CTV.
We then examined if other C1 CTV derivatives, presenting
an inverted arrangement of one of their aromatic rings, could
be obtained following our method. Using the same procedure
and starting from the 1:1 mixture of the two regioisomers 11
and 12, a mixture of C3 and C1 CTV 9 was obtained in 46%
yield, with a C3/C1 ratio of 25/75 in agreement with the
previously established statistical model. The subsequent
deprotection of the allyl groups then affords the C3 and C1
CTV 10 in 90% yield (Scheme 2). Resolution of CTVs 9 and
10 was performed on chiral HPLC (see the Supporting
Information). As previously observed with CTV-5, the
chiroptical properties of the C1 CTVs 9 and 10 are one-third
of those of their C3 parents. The absolute configurations of
these C1 CTVs were assigned using the same strategy as that
described for C1 CTV 5. Furthermore, it should be noted that
various functional groups can be easily grafted on the phenol
function of C1 CTV 10, allowing for a straightforward tuning of
its properties and making it a promising cyclophane building
block. Single crystals suitable for X-ray diffraction studies of C1
CTV-9 and C1 CTV-10 were obtained by slow diffusion of
pentane and ether, respectively, in chloroform solutions
(Figure 4 and Figures S104 and 105). These compounds
display the expected bowl-shaped structure, with the
permutation of the spatial arrangement of the substituents
on one of the aromatic rings. The angles formed between the
oxygen atoms bearing the bulky substituents and their
barycenter are reported in Figure 4b, highlighting the
difference between the three intervals, induced by the
desymmetrization.
We have thus described the unprecedented synthesis of
enantiopure C1-symmetrical CTVs. The C3 symmetry,
classically observed with CTV derivatives, was successfully
broken following a novel approach based on the inversion of
the position of the two alkoxy groups of one of the aromatic
rings. This leads to original enantiopure bowl-shaped cyclo-
phanes with novel structural and optical properties. Impor-
tantly, the C1 CTV scaffold obtained following this approach
Figure 3. Proportion of C3 CTV-8 (in red) and C1 CTV-5 (in blue)
obtained with different initial proportions x of isomer 7 for the
cyclization. Triangles represent the experimental proportions, and the
line represents the binomial statistical model.
Scheme 2. Synthesis of C1 CTV-9 and -10
Figure 4. (a) X-ray crystal structure of (−)-P−C1 CTV-9. (b) Angles
between the bulky linkers.
represents a new tool for the construction of molecular cages
with three apertures of different sizes. In addition, this is a
promising strategy for the fine-tuning of the in/out kinetics of
guest encapsulation inside the cryptophane cavity, while
retaining high affinity. As the C1 CTVs precursors can be
easily obtained in a gram scale, we envision that library of such
challenging building blocks can be rapidly built.
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